- This event has passed.
BioForum – Advancements in targeted drug delivery: Exploring nasal, pulmonary, ophthalmic and dermal systems – SOLD OUT
December 3 @ 8:45 am - 12:00 pm AEDT
Event Navigation
SOLD OUT – Join the waitlist.
Join us for an in-depth exploration of the critical role of drug delivery systems, focusing on the nasal, pulmonary, ocular, and dermal routes. These advances in delivery methods are reshaping modern therapeutics by providing significant advantages over traditional oral or intravenous methods, including enhanced patient compliance, targeted treatment, and improved bioavailability.
The seminar highlights how these systems are revolutionising the landscape of personalised medicine to reduce invasiveness and improve treatment precision. By expanding therapeutic options and boosting patient outcomes, these innovative routes are at the forefront of drug formulation advancements.
Be informed about:
- Pulmonary Drug Delivery
Targeting the lungs directly allows for lower doses, reducing side effects and maximizing therapeutic impact, particularly for respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Additionally, pulmonary delivery holds potential for treating systemic diseases due to the large surface area and high permeability of the alveolar region, allowing for rapid absorption in the bloodstream
- Nasal Drug Delivery
Nasal route can be used for both local and systemic drug delivery. The nasal route is being explored for central nervous system conditions, like epilepsy, Alzheimer’s, etc. Nasal delivery also supports self-administration and rapid absorption through the nasal mucosa, making it crucial for conditions requiring immediate therapeutic effects, such as migraines and certain emergency medications
- Ophthalmic Drug Delivery
The eye is a delicate organ that requires targeted approaches to address conditions such as glaucoma, dry eye and retinal diseases. Preservatives in eye drops affect the retinal surface especially on long term usage. Preservative free delivery systems can help eliminate preservatives from formulations thereby reducing these side effect
- Dermal Drug Delivery
The skin provides an accessible and non-invasive route for systemic or localized drug delivery. This route is highly suitable for drugs that are poorly absorbed orally or prone to degradation in the digestive tract
What to expect:
- The latest updates from industry experts
- Engaging information for diverse audiences
- Dynamic panel Q&A session
- In-person networking opportunities with peers.
Who should attend?
- Professionals in R&D, focusing on innovation and advancement within biotech and healthtech sectors.
- Senior leaders overseeing CMC (Chemistry, Manufacturing, and Controls) who are pivotal in transitioning products from development to manufacturing.
- Product Development leaders and experts driving the strategic and technical development of new therapies and technologies.
- Analytical professionals in testing, validation, and quality control throughout the product lifecycle.
- Project, Product, Formulation, and Process Development specialists involved in the end-to-end planning and execution of biopharma projects.
- Business and Pharmaceutical Development professionals focused on advancing commercially viability and market readiness of new products.
- Packaging Engineers and Specialists working to ensure safe, compliant, and sustainable product packaging solutions.
Event details:
Date: Tuesday 3 December 2024
Time (AEDT):
8:45 am: Guest arrival and registration
9:00 am: Networking tea and coffee
9:30 am: Welcome and opening remarks
9:35 am: Presentations and Q&A
10:55 am: Closing remarks
11:00 am: Networking lunch
12:00 pm: Close
Format: In-person only
Venue: Burke & Wills Suite, Batman’s Hill on Collins, 623 Collins Street, Melbourne 3000, VIC
Speakers:
Shraddha Dangat, Senior Manager, Sales and Service Champion SEA, Aptar Pharma
Pankaj Sonawane, Director, Sales & Customer Service, India and SEA, Aptar Pharma
Dr Shadab Haque, Senior Research Scientist – Biologics, Medicines Manufacturing Innovation Centre
Dr Grant Mclachlan PhD, Director, CMC Program Management, ENA Respiratory
Host: Karen Parr, CEO, BioMelbourne Network
Registration:
Free to attend for Members and Non Members, registration is essential.
Unsure if your organisation is a member? Check our member directory.
Sponsored by Aptar Pharma
Shraddha Dangat, Senior Manager, Sales and Service Champion SEA, Aptar Pharma
Shraddha Dangat, Senior Manager | Sales and Service Champion SEA, Aptar Pharma is a highly accomplished professional with over 15 years of experience in the pharmaceutical industry. She has worked across industry in different roles prior to joining Aptar. Currently serving as Sr. Manager at Aptar Pharma, Shraddha specializes in market development and driving regional growth initiatives with a specific focus on strategizing for the growth of Aptar Pharma Services.
Shraddha has completed her Professional Certificate in Strategic Management from IIM Kozhikode and her master’s in pharmacy from Aston University in the UK.
Shraddha has completed her Professional Certificate in Strategic Management from IIM Kozhikode and her master’s in pharmacy from Aston University in the UK.
Pankaj Sonawane, Director, Sales & Customer Service, India and SEA, Aptar Pharma
Pankaj is a chemical technologist with specialization in polymers. He has extensive experience in sales and business development of packaging and drug delivery systems. Pankaj leverages his in-depth understanding of the drug delivery systems to drive successful sales strategies and growth initiatives. His experience of leading cross-functional teams enables him to align business goals with technical requirements ensuring smooth project execution and client satisfaction.
Pankaj is currently Director | Sales & Customer Service at Aptar Pharma for India and SEA.
Pankaj is currently Director | Sales & Customer Service at Aptar Pharma for India and SEA.
Dr Shadab Haque, Senior Research Scientist - Biologics, Medicines Manufacturing Innovation Centre
Dr Shadab Haque is our expert in formulation development of therapeutic peptides and proteins for intravenous, oral, intranasal and inhalation delivery and has extensive experience in developing both immediate and controlled release formulations of peptides, proteins and small molecule drugs.
Shadab has over ten years of research experience working in Australia and India. Prior to his current role, he was a research fellow at the ARC Center of Excellence in Convergent Bio-Nano Science & Technology, where he worked on lipid-based DNA and RNA delivery systems, and a research fellow at Lonza Pharma Biotech and Nutrition, where he developed novel lipid formulations of peptides, and its lipophilic salts for oral delivery. During Shadab’s PhD studies at the Monash Institute of Pharmaceutical Science (MIPS), he received several notable awards and accolades for his research and was invited to attend many international and national conferences to present his work. He was one of the three recipients of the prestigious “Victoria India Doctoral Scholarship’’, and his thesis was ranked in the top 1-5% band in the field by Monash University.
Shadab has over ten years of research experience working in Australia and India. Prior to his current role, he was a research fellow at the ARC Center of Excellence in Convergent Bio-Nano Science & Technology, where he worked on lipid-based DNA and RNA delivery systems, and a research fellow at Lonza Pharma Biotech and Nutrition, where he developed novel lipid formulations of peptides, and its lipophilic salts for oral delivery. During Shadab’s PhD studies at the Monash Institute of Pharmaceutical Science (MIPS), he received several notable awards and accolades for his research and was invited to attend many international and national conferences to present his work. He was one of the three recipients of the prestigious “Victoria India Doctoral Scholarship’’, and his thesis was ranked in the top 1-5% band in the field by Monash University.
Dr Grant Mclachlan PhD, Director, CMC Program Management, ENA Respiratory
Grant joined ENA Respiratory in 2020, overseeing the CMC activities. Grant has over 25 years of experience in drug development, including managing CMC activities. He has a Ph.D. in Chemistry from Monash University Australia, and completed a post-doctoral in the USA. Upon returning to Australia, he joined IDT Australia, where he was focused on API process development and scale-up for clinical trial and commercial supply. Following a stint at Melbourne Ventures, where he was Project Manager and was responsible for a number of the University of Melbourne’s research translation and commercialisation opportunities, Grant joined Armaron Bio as CEO. He led Armaron through fund raising, pre-clinical development to the completion of a Phase II clinical trial.
Related Events
